Literature DB >> 11445283

Fastigiovestibular projections in the rat: retrograde tracing coupled with gammaamino-butyric acid and glutamate immunohistochemistry.

M Diagne1, C Delfini, P Angaut, P Buisseret, C Buisseret-Delmas.   

Abstract

In this study, a double labeling technique using retrograde tracing with protein-gold complex (gold-HRP) in conjunction with a gammaamino-butyric acid (GABA) and glutamate immunohistochemical procedure was performed to identify GABA (GABA-IR) and glutamate (Glu-IR) immunoreactive neurons in the cerebellar fastigial nucleus (FN) that projects to the vestibular nuclei (VN). The results show that FN neurons projecting to the VN consist of both GABA-IR and Glu-IR neurons with a predominance of glutamatergic ones. Because GABAergic neurons in the cerebellar nuclei project to the inferior olive (IO), double retrograde labeling experiments were performed with injections of gold-HRP in the IO and of biotilynated dextran amine in the VN. This showed that the GABA-IR fastigiovestibular neurons project by axon collaterals to both the VN and the IO.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445283     DOI: 10.1016/s0304-3940(01)01969-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Depolarization-induced release of amino acids from the vestibular nuclear complex.

Authors:  Donald A Godfrey; Yizhe Sun; Christopher Frisch; Matthew A Godfrey; Allan M Rubin
Journal:  Neurochem Res       Date:  2011-12-07       Impact factor: 3.996

2.  Comparison of gamma-aminobutyrate receptors in the medial vestibular nucleus of control and Scn8a mutant mice.

Authors:  Yizhe Sun; Donald A Godfrey; Kejian Chen; Leslie K Sprunger; Allan M Rubin
Journal:  Brain Res       Date:  2007-10-17       Impact factor: 3.252

3.  Decreased Wave V Amplitude in Auditory Brainstem Responses of Children with Cerebellar Lesions.

Authors:  Yuka Matsuura; Masayoshi Oguri; Yoshiaki Saito; Yasutaka Aoe; Ayame Ogawa; Shota Akiyama; Nanako Yasuda; Kengo Sato; Yoshihiro Maegaki; Yasuaki Hirooka
Journal:  Yonago Acta Med       Date:  2018-12-27       Impact factor: 1.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.